Argent Trust Co Has $2.05 Million Holdings in Quest Diagnostics Inc (DGX)

Argent Trust Co grew its position in shares of Quest Diagnostics Inc (NYSE:DGX) by 2.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 24,575 shares of the medical research company’s stock after purchasing an additional 653 shares during the period. Argent Trust Co’s holdings in Quest Diagnostics were worth $2,046,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in DGX. Levin Capital Strategies L.P. acquired a new stake in shares of Quest Diagnostics during the 4th quarter worth about $119,754,000. American Century Companies Inc. boosted its stake in shares of Quest Diagnostics by 38.7% during the 3rd quarter. American Century Companies Inc. now owns 4,109,526 shares of the medical research company’s stock worth $443,459,000 after purchasing an additional 1,147,470 shares during the last quarter. Marshall Wace LLP boosted its stake in shares of Quest Diagnostics by 105.1% during the 3rd quarter. Marshall Wace LLP now owns 1,525,559 shares of the medical research company’s stock worth $164,623,000 after purchasing an additional 781,703 shares during the last quarter. Bank of New York Mellon Corp boosted its stake in shares of Quest Diagnostics by 57.3% during the 2nd quarter. Bank of New York Mellon Corp now owns 1,781,373 shares of the medical research company’s stock worth $195,845,000 after purchasing an additional 648,706 shares during the last quarter. Finally, Macquarie Group Ltd. boosted its stake in shares of Quest Diagnostics by 4.8% during the 3rd quarter. Macquarie Group Ltd. now owns 6,708,232 shares of the medical research company’s stock worth $723,882,000 after purchasing an additional 306,017 shares during the last quarter. 87.19% of the stock is currently owned by institutional investors.

Several research firms have issued reports on DGX. Citigroup decreased their price target on shares of Quest Diagnostics from $112.00 to $104.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 24th. Zacks Investment Research cut shares of Quest Diagnostics from a “hold” rating to a “sell” rating in a research report on Wednesday, February 6th. Canaccord Genuity decreased their target price on shares of Quest Diagnostics from $118.00 to $105.00 and set a “buy” rating on the stock in a research report on Wednesday, October 24th. William Blair reissued an “outperform” rating on shares of Quest Diagnostics in a research report on Tuesday, October 23rd. Finally, Barclays decreased their target price on shares of Quest Diagnostics from $125.00 to $117.00 and set an “overweight” rating on the stock in a research report on Friday, November 30th. Two analysts have rated the stock with a sell rating, nine have given a hold rating and nine have given a buy rating to the company. The company currently has a consensus rating of “Hold” and an average price target of $104.56.

DGX opened at $89.88 on Thursday. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.09 and a current ratio of 1.15. Quest Diagnostics Inc has a 1 year low of $78.95 and a 1 year high of $116.49. The company has a market capitalization of $12.21 billion, a P/E ratio of 16.64, a P/E/G ratio of 1.83 and a beta of 0.89.

The firm also recently declared a quarterly dividend, which was paid on Wednesday, January 30th. Shareholders of record on Tuesday, January 15th were given a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a yield of 2.36%. This is a boost from Quest Diagnostics’s previous quarterly dividend of $0.50. The ex-dividend date was Monday, January 14th. Quest Diagnostics’s payout ratio is 39.26%.

TRADEMARK VIOLATION WARNING: “Argent Trust Co Has $2.05 Million Holdings in Quest Diagnostics Inc (DGX)” was reported by Community Financial News and is the property of of Community Financial News. If you are accessing this piece of content on another site, it was stolen and reposted in violation of United States & international trademark and copyright legislation. The legal version of this piece of content can be read at https://www.com-unik.info/2019/02/14/argent-trust-co-has-2-05-million-holdings-in-quest-diagnostics-inc-dgx.html.

Quest Diagnostics Company Profile

Quest Diagnostics Incorporated provides diagnostic testing information and services in the United States and internationally. The company's Diagnostic Information Services business segment develops and delivers diagnostic testing information and services, such as routine testing, non-routine and advanced clinical testing, gene-based and esoteric testing, anatomic pathology, and other diagnostic information services.

Recommended Story: Rule of 72

Want to see what other hedge funds are holding DGX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Quest Diagnostics Inc (NYSE:DGX).

Institutional Ownership by Quarter for Quest Diagnostics (NYSE:DGX)

Receive News & Ratings for Quest Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quest Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit